Diarrhoea: Comprehensive Management Guide

Overview

Diarrhoea is one of the most common health complaints worldwide, affecting billions of people annually and representing a significant cause of morbidity and mortality, particularly in developing countries and among vulnerable populations such as children and the elderly. Defined as the passage of three or more loose or watery stools per day, diarrhoea is a symptom rather than a disease, with causes ranging from simple dietary indiscretions to serious systemic illnesses requiring immediate medical intervention.

Understanding that diarrhoea represents a disruption in the normal balance between fluid absorption and secretion in the intestinal tract is crucial for effective management. The primary concern in diarrhoeal illnesses is preventing and treating dehydration, which can rapidly become life-threatening, especially in vulnerable populations. While most cases of acute diarrhoea are self-limiting and resolve within a few days, proper assessment, supportive care, and recognition of when professional medical intervention is required are essential for optimal outcomes.

Understanding Normal Bowel Function and Diarrhoeal Pathophysiology

Normal Intestinal Fluid Handling

Daily Fluid Balance:

Fluid Input: Approximately 8-10 liters daily (oral intake, saliva, gastric, biliary, pancreatic, and intestinal secretions)
Small Intestine Absorption: 7-8 liters reabsorbed in jejunum and ileum
Colon Absorption: 1-2 liters reabsorbed, leaving 100-200ml in normal stool
Water Content: Normal stool is 60-85% water
Electrolyte Balance: Sodium, chloride, potassium, and bicarbonate regulation

Normal Stool Characteristics:

Frequency: 3 times daily to 3 times weekly
Volume: 100-300g daily
Consistency: Formed, soft consistency (Bristol Stool Scale 3-4)
Color: Brown due to bile pigments
Composition: 75% water, 25% solids (bacteria, fiber, fat, protein)

Pathophysiology of Diarrhoea

Secretory Diarrhoea:

Mechanism: Increased intestinal secretion without mucosal damage
Characteristics: Large volume, watery, no blood or mucus
Causes: Bacterial toxins, hormones, medications
Electrolyte Pattern: High sodium content, osmotic gap <50 mOsm/kg
Response: Continues during fasting

Osmotic Diarrhoea:

Mechanism: Unabsorbed solutes draw water into intestinal lumen
Characteristics: Stops with fasting, stool osmotic gap >100 mOsm/kg
Causes: Lactose intolerance, sorbitol, magnesium-containing antacids
Volume: Usually moderate, improves with dietary modification
pH: Often acidic due to carbohydrate malabsorption

Inflammatory Diarrhoea:

Mechanism: Mucosal invasion and damage causing inflammation
Characteristics: Blood, mucus, fever, abdominal pain
Causes: Bacterial invasion, inflammatory bowel disease
Volume: Small to moderate volumes
Markers: Elevated fecal leukocytes, lactoferrin, calprotectin

Motility Disorders:

Mechanism: Altered intestinal motility affecting transit time
Rapid Transit: Insufficient time for fluid absorption
Causes: Hyperthyroidism, irritable bowel syndrome, medications
Characteristics: Variable consistency, associated with urgency
Response: May respond to antimotility agents

Etiology and Classification

Acute Diarrhoea (Duration <14 days)

Infectious Causes

Viral Gastroenteritis (Most Common):

Rotavirus: Leading cause in children worldwide
Norovirus: Common cause of outbreaks in closed settings
Adenovirus: Particularly serotypes 40 and 41
Astrovirus: Mild symptoms, mainly in children
Sapovirus: Similar to norovirus, less common

Bacterial Infections:

Salmonella: Food poisoning, invasive disease possible
Campylobacter jejuni: Most common bacterial cause in developed countries
Clostridium difficile: Antibiotic-associated diarrhoea
Escherichia coli: Various pathotypes (ETEC, EPEC, EIEC, EHEC)
Shigella: Highly contagious, bloody diarrhoea
Vibrio cholerae: Severe secretory diarrhoea, epidemic potential

Parasitic Infections:

Giardia lamblia: Most common parasitic cause
Cryptosporidium: Particularly severe in immunocompromised
Entamoeba histolytica: Amoebic dysentery
Cyclospora: Associated with fresh produce
Microsporidia: Opportunistic infection in AIDS patients

Non-Infectious Acute Causes

Food-Related:

Food Poisoning: Bacterial toxins (Staphylococcus aureus, Bacillus cereus)
Lactose Intolerance: Dairy product consumption
Food Allergies: IgE-mediated reactions
Artificial Sweeteners: Sorbitol, mannitol in large quantities
Spicy Foods: Direct irritation of intestinal mucosa

Medication-Induced:

Antibiotics: Disruption of normal flora
Magnesium-Containing Antacids: Osmotic effect
Proton Pump Inhibitors: Increased infection risk
Chemotherapy: Direct mucosal toxicity
NSAIDs: Inflammatory changes

Chronic Diarrhoea (Duration >4 weeks)

Inflammatory Conditions

Inflammatory Bowel Disease:

Crohn’s Disease: Can affect any part of GI tract
Ulcerative Colitis: Limited to colon and rectum
Microscopic Colitis: Lymphocytic and collagenous subtypes
Ischemic Colitis: Vascular insufficiency
Radiation Enteritis: Following radiation therapy

Malabsorption Syndromes

Celiac Disease: Gluten sensitivity causing villous atrophy Pancreatic Insufficiency: Chronic pancreatitis, cystic fibrosis Bile Acid Malabsorption: Terminal ileal disease or dysfunction Short Bowel Syndrome: Surgical resection or congenital abnormalities Whipple’s Disease: Rare systemic infection

Functional Disorders

Irritable Bowel Syndrome: Diarrhoea-predominant subtype Functional Diarrhoea: Rome criteria-defined functional disorder Carbohydrate Intolerance: Lactose, fructose, sucrose malabsorption Bile Acid Diarrhoea: Primary or secondary bile acid malabsorption

Endocrine and Systemic Causes

Hyperthyroidism: Increased intestinal motility Diabetes: Diabetic enteropathy, bacterial overgrowth Carcinoid Syndrome: Serotonin-producing tumors Zollinger-Ellison Syndrome: Gastrinomas causing acid hypersecretion Systemic Mastocytosis: Mast cell mediator release

Clinical Assessment and Evaluation

History and Symptom Assessment

Stool Characteristics:

Frequency: Number of bowel movements per day
Volume: Large volume suggests small bowel, small volume suggests colon
Consistency: Watery, loose, bloody, mucoid
Color: Pale (malabsorption), bloody (inflammatory), black (upper GI bleeding)
Associated Features: Blood, mucus, undigested food, oil droplets

Associated Symptoms:

Systemic: Fever, malaise, dehydration signs
Gastrointestinal: Nausea, vomiting, abdominal pain, cramping
Urgency: Feeling of incomplete evacuation, tenesmus
Incontinence: Inability to control bowel movements
Weight Loss: Suggests malabsorption or chronic inflammation

Epidemiological Factors:

Onset: Acute vs. gradual
Duration: Days, weeks, or months
Travel History: Recent travel to endemic areas
Food History: Recent meals, water sources, restaurant dining
Contact History: Ill family members, outbreak situations
Medication History: Recent antibiotics, new medications

Physical Examination

General Assessment:

Hydration Status: Skin turgor, mucous membranes, orthostatic changes
Vital Signs: Temperature, blood pressure, heart rate
Weight: Current weight vs. baseline
General Appearance: Toxic vs. well-appearing
Lymphadenopathy: Suggests systemic illness

Abdominal Examination:

Inspection: Distension, visible peristalsis
Auscultation: Bowel sounds (hyperactive, hypoactive, absent)
Percussion: Tympany, organomegaly
Palpation: Tenderness, masses, hepatosplenomegaly
Rectal Examination: When indicated, assess for masses, blood

Dehydration Assessment

Mild Dehydration (3-5% fluid loss):

Clinical Signs: Slightly dry mucous membranes, normal skin turgor
Symptoms: Mild thirst, normal urine output
Vital Signs: Usually normal
Mental Status: Alert and oriented
Management: Oral rehydration usually sufficient

Moderate Dehydration (6-9% fluid loss):

Clinical Signs: Dry mucous membranes, decreased skin turgor
Symptoms: Moderate thirst, decreased urine output
Vital Signs: Mild tachycardia, orthostatic changes
Mental Status: May be irritable or restless
Management: Aggressive oral or IV rehydration

Severe Dehydration (≥10% fluid loss):

Clinical Signs: Very dry mucous membranes, tenting skin
Symptoms: Intense thirst or absent (altered consciousness)
Vital Signs: Tachycardia, hypotension, weak pulse
Mental Status: Confusion, lethargy, or unconsciousness
Management: Immediate IV rehydration, hospitalization

Diagnostic Testing and Laboratory Evaluation

Initial Assessment

Basic Laboratory Tests:

Electrolytes: Sodium, potassium, chloride, bicarbonate
Renal Function: BUN, creatinine
Complete Blood Count: Hemoglobin, white blood cell count
Inflammatory Markers: C-reactive protein, erythrocyte sedimentation rate
Albumin: Assessment of nutritional status

Stool Analysis

Routine Stool Examination:

Gross Appearance: Color, consistency, blood, mucus
Microscopy: Fecal leukocytes, red blood cells, ova and parasites
pH: Acidic suggests carbohydrate malabsorption
Osmotic Gap: Calculation: 290 - 2(Na + K) in stool water
Occult Blood: Detection of hidden blood

Microbiological Studies:

Bacterial Culture: Salmonella, Shigella, Campylobacter, E. coli
Clostridium difficile: Toxin assay, PCR, or enzyme immunoassay
Viral Studies: Rotavirus, norovirus antigen detection
Parasitology: Multiple samples for ova and parasites
Special Studies: Cryptosporidium, Giardia antigen, Cyclospora

Advanced Testing (For Chronic Diarrhoea)

Inflammatory Markers:

Fecal Calprotectin: Elevated in inflammatory bowel disease
Fecal Lactoferrin: Marker of neutrophil activity
Fecal Alpha-1 Antitrypsin: Protein-losing enteropathy

Malabsorption Studies:

Fecal Fat: 72-hour collection for steatorrhea
D-Xylose Test: Small bowel absorption
Lactose Tolerance Test: Lactase deficiency
Pancreatic Function: Fecal elastase, chymotrypsin

Endoscopic Evaluation:

Flexible Sigmoidoscopy: Lower colon evaluation
Colonoscopy: Complete colon examination with biopsy
Upper Endoscopy: Duodenal biopsy for celiac disease
Capsule Endoscopy: Small bowel visualization

Evidence-Based Treatment Approaches

Fluid and Electrolyte Replacement

Oral Rehydration Therapy (ORT)

WHO/UNICEF Recommended Formula:

Composition: Sodium 75 mmol/L, chloride 65 mmol/L, glucose 75 mmol/L, potassium 20 mmol/L
Osmolarity: 245 mOsm/L (reduced from previous 311 mOsm/L)
Benefits: Reduces stool output, vomiting, need for IV fluids
Efficacy: Effective for mild to moderate dehydration
Administration: Small, frequent volumes (5-10ml every few minutes)

Commercial ORS Products:

Pedialyte: Pediatric formulation, multiple flavors
CeraLyte: Rice-based formula, may be better tolerated
DripDrop: Enhanced taste, higher sodium content
Liquid IV: Powder packets for water mixing
WHO Packets: Available through international organizations

Homemade Solutions (Emergency Use):

Basic Recipe: 1 teaspoon salt + 2 tablespoons sugar in 1 quart water
Enhanced: Add 1/4 teaspoon potassium chloride (salt substitute)
Limitations: Less precise electrolyte balance
Safety: Ensure accurate measurements
Recommendation: Use commercial products when available

Intravenous Fluid Therapy

Indications for IV Therapy:

Severe Dehydration: >10% fluid loss
Intractable Vomiting: Unable to tolerate oral fluids
High Output: >10ml/kg/hour stool losses
Hemodynamic Instability: Hypotension, tachycardia
Altered Mental Status: Confusion, lethargy

Fluid Selection:

Initial Resuscitation: Normal saline or Ringer’s lactate
Maintenance: Balanced solutions with appropriate electrolytes
Potassium Replacement: After ensuring adequate urine output
Bicarbonate: For significant acidosis
Rate: Based on degree of dehydration and ongoing losses

Symptomatic Treatments

Antimotility Agents

Loperamide (Imodium):

Mechanism: Opioid receptor agonist, slows intestinal transit
Dosing: 4mg initial, then 2mg after each loose stool (max 16mg/day)
Indications: Non-bloody diarrhoea, cramping
Contraindications: High fever, bloody stools, suspected C. diff
Benefits: Reduces frequency, improves consistency

Diphenoxylate/Atropine (Lomotil):

Mechanism: Similar to loperamide with anticholinergic effects
Dosing: 2 tablets four times daily initially
Considerations: Prescription required, abuse potential
Side Effects: Drowsiness, dry mouth, blurred vision
Age Restrictions: Not recommended in children <2 years

Adsorbents and Protectants

Bismuth Subsalicylate (Pepto-Bismol):

Mechanism: Anti-inflammatory, antimicrobial, adsorbent properties
Dosing: 525mg every 30 minutes for up to 8 doses
Indications: Traveler’s diarrhoea, mild gastroenteritis
Contraindications: Salicylate allergy, children with viral illness
Side Effects: Black tongue, dark stools

Kaolin-Pectin Products:

Mechanism: Adsorb toxins and provide bulk
Efficacy: Limited clinical evidence
Safety: Generally safe but may interfere with drug absorption
Preference: Less effective than other agents
Use: Historical use, less commonly recommended

Probiotics

Lactobacillus rhamnosus GG:

Evidence: Best studied probiotic for diarrhoea
Efficacy: Reduces duration by 1-2 days
Mechanism: Restores normal flora, immune modulation
Safety: Generally safe in immunocompetent individuals
Timing: Most effective when started early

Saccharomyces boulardii:

Unique: Yeast probiotic, resistant to antibiotics
Indications: Antibiotic-associated diarrhoea, C. diff prevention
Dosing: 250-500mg twice daily
Evidence: Good for prevention and treatment
Safety: Avoid in immunocompromised or central line patients

Antimicrobial Therapy

Indications for Antibiotics

Clear Bacterial Infection: Positive culture with susceptible organism Severe Illness: High fever, severe dehydration, bloody stools Immunocompromised: Higher risk for complications Specific Pathogens: Cholera, shigellosis, campylobacter with bacteremia Traveler’s Diarrhoea: Empiric therapy for moderate-severe symptoms

Antibiotic Selection

Fluoroquinolones:

Ciprofloxacin: 500mg twice daily for 3-5 days
Levofloxacin: 500mg daily for 3-5 days
Broad Spectrum: Effective against most bacterial causes
Resistance: Increasing resistance, particularly Campylobacter
Contraindications: Pregnancy, children, tendon problems

Macrolides:

Azithromycin: 500mg daily for 3 days or 1000mg single dose
Clarithromycin: 500mg twice daily for 3-5 days
Preferred: For Campylobacter, areas with quinolone resistance
Safety: Better safety profile than quinolones
Pediatric: Safe in children

Rifaximin:

Mechanism: Non-absorbed antibiotic
Indications: Traveler’s diarrhoea (E. coli)
Dosing: 200mg three times daily for 3 days
Limitations: Not effective for invasive pathogens
Safety: Minimal systemic absorption

Specific Condition Management

Antibiotic-Associated Diarrhoea

Clostridium difficile Infection:

Mild-Moderate: Oral vancomycin 125mg four times daily
Severe: Oral vancomycin 500mg four times daily
Recurrent: Tapered vancomycin regimen or fidaxomicin
Fulminant: IV metronidazole plus oral/rectal vancomycin
FMT: Fecal microbiota transplant for recurrent cases

Traveler’s Diarrhoea

Prevention:

Food Safety: Avoid high-risk foods and water
Prophylaxis: Bismuth subsalicylate, rifaximin in high-risk situations
Vaccination: Cholera vaccine for endemic areas
Education: Proper food and water precautions

Treatment:

Mild: Fluid replacement, bismuth subsalicylate
Moderate: Add loperamide for symptom control
Severe: Antibiotics (azithromycin preferred)
Duration: Usually 3-5 days of treatment

Special Populations and Considerations

Pediatric Diarrhoea

Infants (<6 months):

Breastfeeding: Continue breastfeeding throughout illness
Formula: May continue regular formula or switch to lactose-free
ORS: Pedialyte or similar pediatric formulations
Volumes: 10ml/kg for each loose stool
Warning Signs: Lethargy, poor feeding, decreased urine output

Children (6 months - 5 years):

Dietary: Resume normal diet as tolerated (BRAT diet not necessary)
ORS: 50-100ml after each loose stool
Medications: Avoid antimotility agents in children
Probiotics: May be beneficial, particularly Lactobacillus GG
School: Exclude until 48 hours after last loose stool

Adolescents:

Similar to Adults: Can use adult dosing for most medications
School Activities: May need restriction from swimming, sports
Education: Proper hygiene, hand washing
Complications: Monitor for severe dehydration
Antibiotics: Use when clearly indicated

Elderly Patients

Increased Risk Factors:

Comorbidities: Diabetes, kidney disease, heart failure
Medications: Multiple drugs increasing risk
Immune Status: Age-related immunosenescence
Functional Status: May have difficulty with self-care
C. difficile: Higher risk due to antibiotic exposure

Management Considerations:

Conservative: Lower threshold for IV fluids
Monitoring: More intensive monitoring required
Medications: Careful dosing, avoid if possible
Setting: May require hospitalization more often
Recovery: Slower recovery, longer convalescence

Immunocompromised Patients

HIV/AIDS:

Opportunistic Infections: Cryptosporidium, Microsporidia, CMV
Chronic Diarrhoea: May require extensive evaluation
Treatment: Immune restoration most important
Antimicrobials: Often require specific therapy

Organ Transplant Recipients:

Drug-Related: Immunosuppressive medications
Infections: Higher risk of severe infections
C. difficile: Common and severe
Management: Often requires specialist consultation

Pregnant Women

Physiological Changes: Normal pregnancy may alter bowel habits Medication Safety: Limited options for safe medications Dehydration Risk: Can affect fetal well-being Specific Concerns: Listeria, E. coli O157:H7 risks Management: Conservative approach, avoid unnecessary medications

Prevention Strategies

Food and Water Safety

High-Risk Foods to Avoid:

Raw or Undercooked: Meat, poultry, seafood, eggs
Dairy: Unpasteurized milk and dairy products
Produce: Raw vegetables, fruits that cannot be peeled
Street Food: Vendor-prepared foods without proper hygiene
Buffets: Foods at room temperature for extended periods

Safe Food Practices:

Cook Thoroughly: Internal temperatures >160°F for meat
Keep Hot Foods Hot: >140°F, cold foods <40°F
Clean Hands: Wash before eating and food preparation
Separate: Raw and cooked foods
Refrigerate: Promptly refrigerate leftovers

Water Safety:

Bottled Water: Sealed, reputable brands
Boiling: 1 minute at sea level, 3 minutes at altitude
Purification: Water purification tablets, UV sterilizers
Ice: Only from safe water sources
Beverages: Hot beverages, carbonated drinks generally safer

Personal Hygiene

Hand Hygiene:

Frequency: Before eating, after bathroom use, after contact with potentially contaminated surfaces
Technique: Soap and water for 20 seconds, alcohol-based sanitizer when soap unavailable
Critical Times: After changing diapers, before food preparation
Family Members: Ensure all family members practice good hygiene
Public Facilities: Extra caution in public restrooms

Travel Precautions

Pre-Travel Consultation:

Risk Assessment: Destination-specific risks
Vaccinations: Hepatitis A, typhoid, cholera when indicated
Medications: Prophylactic antibiotics in high-risk situations
Education: Food, water, and hygiene precautions
Insurance: Travel health insurance coverage

During Travel:

Food Selection: Choose freshly cooked, hot foods
Water: Stick to bottled or purified water
Restaurants: Select busy establishments with high turnover
Street Vendors: Generally avoid unless clearly safe
Swimming: Avoid swimming in contaminated water

Complications and When to Seek Medical Care

Signs Requiring Immediate Medical Attention

Severe Dehydration Signs:

Mental Status Changes: Confusion, lethargy, unconsciousness
Cardiovascular: Weak pulse, low blood pressure, dizziness
Renal: Little or no urination for 12+ hours
Skin: Very dry skin that tents when pinched
Eyes: Sunken eyes, no tears when crying

Alarming Symptoms:

High Fever: Temperature >101.3°F (38.5°C)
Blood in Stool: Visible blood or black, tarry stools
Severe Abdominal Pain: Intense, constant abdominal pain
Persistent Vomiting: Unable to keep fluids down
Signs of Sepsis: Fever, confusion, rapid breathing, fast heart rate

Complications of Diarrhoeal Illness

Electrolyte Imbalances:

Hyponatremia: Confusion, seizures, coma
Hypokalemia: Weakness, paralysis, cardiac arrhythmias
Acidosis: Rapid breathing, confusion
Hypocalcemia: Tetany, seizures
Management: Careful electrolyte replacement

Secondary Infections:

Bacteremia: Blood infection from intestinal bacteria
Urinary Tract: Secondary to poor hygiene
Pneumonia: Aspiration in debilitated patients
Skin: Breakdown from frequent stools
Prevention: Proper hygiene, supportive care

Post-Infectious Complications

Post-Infectious Irritable Bowel Syndrome:

Incidence: 5-30% of patients after infectious gastroenteritis
Symptoms: Chronic abdominal pain, altered bowel habits
Duration: May persist for months to years
Risk Factors: Severe initial illness, stress, female gender
Management: Symptomatic treatment, dietary modifications

Reactive Arthritis:

Pathogens: Salmonella, Shigella, Campylobacter, Yersinia
Onset: 2-6 weeks after infection
Symptoms: Joint pain, urethritis, conjunctivitis
Duration: May last months
Treatment: NSAIDs, sometimes immunosuppressives

Medical Disclaimer

This information is for educational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Diarrhoea can be a symptom of serious underlying conditions including inflammatory bowel disease, malabsorption syndromes, infections requiring specific antimicrobial therapy, or other systemic illnesses that require immediate medical evaluation and treatment. Dehydration can rapidly become life-threatening, particularly in infants, elderly individuals, and those with underlying medical conditions. Self-treatment may be inappropriate for severe symptoms, bloody diarrhoea, high fever, or signs of dehydration, and may delay necessary medical care. Some medications may not be appropriate for all patients, and individual responses to treatment can vary significantly. Always consult qualified healthcare professionals including primary care physicians, gastroenterologists, or emergency medicine physicians for accurate diagnosis, appropriate treatment recommendations, and monitoring for complications. Seek immediate medical attention for signs of severe dehydration, persistent high fever, blood in stools, severe abdominal pain, or any concerning symptoms that worsen despite appropriate home management.

Key Message: Diarrhoea is a common condition that ranges from mild, self-limiting illness to potentially life-threatening disease requiring immediate medical intervention. The cornerstone of management is preventing and treating dehydration through appropriate fluid and electrolyte replacement, while addressing underlying causes when specific therapy is indicated. Understanding when to use supportive care versus seeking professional medical evaluation is crucial for optimal outcomes. Most cases of acute diarrhoea resolve with conservative management, but recognizing warning signs and implementing proper prevention strategies are essential skills for maintaining health and preventing serious complications.

Quick Summary